tbuckley/cabot-search huggingface dataset:
The 1983 Oncology Update Symposium
Journal: JNCI Journal of the National Cancer Institute (1982)

Journal Article The 1983 Oncology Update Symposium Get access JNCI: Journal of the National Cancer Institute, Volume 69, Issue 5, November 1982, Page 1205, https://doi.org/10.1093/jnci/69.5.1205-b Published: 01 November 1982
Woman's Medical College of Pennsylvania.
Authors: Henry Leffmann
Journal: JAMA (1895)

Philadelphia, Pa., July 6, 1895. <h3>To the Editor:</h3> —In a recent issue, you reprint the greater part of an editorial appearing in the<i>Medical Press and Circular</i>, concerning the status of American diplomates and, while noting some errors, fail to point out that the " Female Medical College" to which allusion is made in the editorial, is a non-existent institution and has been so for over twenty-five years. The unfavorable light in which the college is placed, may be easily transferred by some persons to the only institution existing in Philadelphia for the instruction of women in medicine, namely, the Woman's Medical College of Pennsylvania. This institution is a member of the Association of American Medical Colleges, has been represented at all its recent meetings and conforms to its requirements. I presume it is hardly necessary to state that the college is in good standing in the medical profession of the
Hepatopulmonary Syndrome
Authors: Pramod Kumar, Padaki N Rao
Journal: New England Journal of Medicine (2020)

A 50-year-old man with cirrhosis presented with shortness of breath. Transthoracic echocardiography, shown in a video, revealed opacification of the chambers on the left side of the heart by microbubbles five heartbeats after the appearance of microbubbles in the right atrium, and a diagnosis of hepatopulmonary syndrome was made.
Enzyme Histochemical Studies on Surgically Resected Breasts
Journal: JAMA (1963)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Geburtshilflich-gynäkologische Propädeutik.
Journal: JAMA (1928)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Convalescence
Authors: Joannie Kervran Stangeland
Journal: JAMA (2006)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Saving the best to the last: Can we wait for second-line?
Authors: Renana Barak, Ido Wolf
Journal: Journal of Clinical Oncology (2020)

7013 Background: A common perception of some oncologists is that the vast majority of their patients with metastatic disease will receive 2nd line treatment upon progression. Therefore, “saving” good treatment options for the future may be acceptable. We aimed to examine whether this perception correlates with real-life. Methods: Using an oncology electronic database, consisting of &gt;27,000 patients treated at our institution, we selected consecutive patients with metastatic or locally advanced lung, colon, pancreatic, bile duct and gastric cancers who started standard 1st line, consisting of at least doublet therapy. We then assessed the correlation between proceeding to 2nd line therapy and demographic and clinical variables, including age, gender, initial BMI, hemoglobin, WBC, creatinine, glucose, calcium, as well as survival. Results: A total of 553 patients met the inclusion criteria. Their median age was 66 and 317 were men. Their diagnoses were colon (197), lung (129), pancreas (101), bile duct (71) and gastric (55) cancers. Only 59% received at least one course of 2nd line treatment (61.9% colon, 65.1% lung, 66.3% pancreas, 35.2% bile duct and 54.5% gastric). Probability of reaching 2nd line treatment was associated with disease site (P=0.0002) as well as with age, with patients who received 2nd line being 2.5 years younger compared to those who did not (65 vs. 67.5 years, P=0.008). No other factor, including gender, BMI or standard laboratory values at presentation could predict chances of proceeding to 2nd line, for either the whole group or by primary cancer origin. Survival of patients not starting 2nd line was also significantly shorter across all tumor types. Conclusions: These real-life data indicate that only 60% of patients starting standard doublet or triplet treatment for advanced cancers will commence 2nd line therapy; and this cannot be reliably predicted in advance using standard clinical and laboratory characteristics. Our data challenge the practice of saving good treatment options for subsequent lines, and call for the development of tools enabling prediction of response and tolerance to treatment, pursuing for better patient selection and patient-tailored therapy.
Contents: (Adv. Healthcare Mater. 5/2017)
Journal: Advanced Healthcare Materials (2017)

A monolayer coating of pyridoxal 5′-phosphate (PLP) on TiO 2 implants shows excellent hemophilicity, platelet inactivation, and osteointegration-inducing properties.Immobilized PLP on implants enhances adsorption of blood proteins and adhesion of platelets, while effectively delays platelet activation and blood coagulation.This enables sufficient supply of growth factors to promote osteoblast adhesion and proliferation, ultimately improving osteointegration to TiO 2 implants.
Vestibular Mechanisms
Authors: W Precht
Journal: Annual Review of Neuroscience (1979)

It is apparent from this and other reviews of the subject that our knowledge of vestibular function is most complete for the primary canal and otolithic afferents. Relatively little progress has been made in the understanding of receptor mechanisms and the functional importance of the efferent vestibular system. Since most of it has been summarized previously the latter were not considered here. Considerably more knowledge has accumulated in the field of central vestibular mechanisms, particularly those related to eye movements. Recent advances in functional synaptology of direct and indirect vestibuloocular pathways are described. It appears that the indirect pathways are essential for the central integration of the peripheral head velocity into a central eye position signal. Candidates for the neural integrator are presented and discussed and their connectivity described both for the horizontal and the relatively poorly studied vertical eye movement system. This field will certainly be studied extensively during the next years. Another interesting field is the role of the cerebellum in the control the vestibuloocular reflex. Recent data and hypotheses, including the problem of cerebellar plasticity, are summarized and evaluated. That the vestibular nuclei are by no means a simple relay system for specific vestibular signals destined for other sensory or motor centers is evidenced in this review by the description of multiple canal-canal, canalotolith, and visual-vestibular convergence at the nuclear level. Canal-otolith and polysensory convergence in vestibular neurons enables them to correct for the inherent inadequacies of the peripheral canal system in the low frequency range. The mechanisms of polysensory interaction in the central vestibular system will undoubtedly be an important and interesting field for future research.
Sniffing gasoline
Authors: M. Bass
Journal: JAMA (1986)

<h3>To the Editor.—</h3> Greer and Giovacchini<sup>1</sup>note that sniffing abuse of gasoline, a complex mixture of hydrocarbons, may result in death. Their letter and the accompanying reply raise the question concerning cause and manner of death associated with gasoline sniffing. In 1970, as part of a nationwide survey on sniffing death in children,<sup>2</sup>I located four cases of sudden death associated with inhalation abuse of gasoline.<sup>3</sup>Each of the sudden sniffing deaths was associated with physical activity or a stressful situation. For example, one sudden death occurred when a youth who was caught sniffing gasoline suddenly ran from police during questioning and fell dead on the street several hundred feet away. Autopsy revealed no anatomic cause of death. Sudden death may occur following gasoline sniffing and blunt trauma to the chest such as a fist punch but without evidence of injury to the heart or other internal
Achievement of complete response (CR) in metastatic or recurrent cervical cancer (MRCC): Does it matter?
Authors: J.F. Grau Béjar, V. Rodriguez Freixinos, L. Fariñas Madrid, G. Villacampa Javierre, A. Gil-Moreno, R. Verges, M.A. Pérez Benavente, A. García, R. Dienstmann, A. Oaknin
Journal: Annals of Oncology (2017)
Making House Calls: Using Telecommunications to Bring Health Care into the Home
Authors: Ron Chepesiuk
Journal: Environmental Health Perspectives (1999)

According to the U.S. Federal Trade Commission, an estimated 22 million Americans used their computers to seek medical information in 1995, making health concerns the sixth most common reason for using the Internet in the United States. Market research firms estimate that the number of people going online for this purpose is growing by 70% annually. Developments in computer technology, the Internet, and wireless and satellite telecommunications have led to major innovations in the nature and delivery of health care that have broad implications for the way people will receive health information and treatment in the future, even allowing health care providers to interact through cyberspace with their patients and other caregivers.
The implications of the 1992 Presidential election for health care reform
Authors: R. J. Blendon
Journal: JAMA (1992)

WHAT message about health reform should our elected officials, the health care community, and the American people take from the 1992 presidential election? As an issue, health care enjoyed considerable prominence in the presidential campaign. But is there sufficient support to pass a health reform plan? And if so, from the voters' perspective, what would such a plan have to look like? This article uses the results of an election night survey of voters, combined with secondary analysis of preelection and election-day exit polls, to examine these questions. The public's responses tell us a great deal about the role of health care in the 1992 election and in the agenda for the newly elected President and Congress. <h3>Data and Methods</h3> The data reported herein are derived primarily from three sources. The first is a national public opinion survey conducted on election night, November 3,1992, by Louis Harris &amp; Associates on
American Journal of Mental Deficiency,Albany,NY
Journal: JAMA (1966)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Effects of Asphyxia on Lung Fluid Balance in Baby Lambs
Journal: Journal of Clinical Investigation (1984)

wrote that the "average duration of hypoxia and hypercapnia was only I h.This was an error.The total duration of hypoxia and hypercapnia was 2 h in the experiments performed by O'Brodovich et al.In addition, Hansen et al. stated that Gorin and Gould, in a previous paper (1979.J. Immunol.123:1339-1342), "showed that both IgG and IgM entered the caudal mediastinal lymph node of the sheep."This too was incorrect because Gorin and Gould actually showed that IgA and IgM are produced in the lung and transported through the caudal mediastinal lymph node of sheep.These corrections do not alter the message of the paper by Hansen et al., which concluded that "in the newborn lamb both alveolar hypoxia and alveolar hypoxia with hypercapnia increase lung lymph flow by increasing filtration pressure in the microcirculation, but neither hypoxia with hypercapnia nor brief severe asphyxia alter the protein permeability of the pulmonary microcirculation."
Malaria: are we prepared?
Authors: C. B. Clayman
Journal: JAMA (1981)

<i>Plasmodium falciparum</i>resistant to chloroquine sulfate has now been documented in two nonimmune travelers exposed in Tanzania and Kenya. Symptoms of malaria developed after their return to the United States. Laboratory studies confirming prior ingestion of chloroquine and showing resistance of the parasites to chloroquine in vitro provide key elements of the documentation. This work adds to the data establishing the presence of chloroquine-resistant<i>P falciparum</i>in Africa. Areas of the world from which chloroquine-resistant<i>P falciparum</i>has been reported now include Kenya, Tanzania, Nigeria, and Ivory Coast in Africa; Brazil, Colombia, Ecuador, French Guiana, Guyana, Panama, Surinam, and Venezuela in the Americas; and Bangladesh, Democratic Kampuchea, India, Indonesia, Laos, Malaysia, Papua New Guinea, the Philippines, Thailand, and Vietnam in Asia. Chloroquine-resistant<i>P falciparum</i>is prevalent throughout malarious areas in some countries such as Thailand; in others it has been documented or reported either sporadically or only in certain parts
Analysis of the genomic landscape of multiple myeloma highlights novel prognostic markers and disease subgroups
Authors: N Bolli, G Biancon, M Moarii, S Gimondi, Y Li, C de Philippis, F Maura, V Sathiaseelan, Y-T Tai, L Mudie, S O’Meara, K Raine, J W Teague, A P Butler, C Carniti, M Gerstung, T Bagratuni, E Kastritis, M Dimopoulos, P Corradini, K Anderson, P Moreau, S Minvielle, P J Campbell, E Papaemmanuil, H Avet-Loiseau, N C Munshi
Journal: Leukemia (2017)

In multiple myeloma, next-generation sequencing (NGS) has expanded our knowledge of genomic lesions, and highlighted a dynamic and heterogeneous composition of the tumor. Here we used NGS to characterize the genomic landscape of 418 multiple myeloma cases at diagnosis and correlate this with prognosis and classification. Translocations and copy number abnormalities (CNAs) had a preponderant contribution over gene mutations in defining the genotype and prognosis of each case. Known and novel independent prognostic markers were identified in our cohort of proteasome inhibitor and immunomodulatory drug-treated patients with long follow-up, including events with context-specific prognostic value, such as deletions of the PRDM1 gene. Taking advantage of the comprehensive genomic annotation of each case, we used innovative statistical approaches to identify potential novel myeloma subgroups. We observed clusters of patients stratified based on the overall number of mutations and number/type of CNAs, with distinct effects on survival, suggesting that extended genotype of multiple myeloma at diagnosis may lead to improved disease classification and prognostication.
Radiolabeled Ligands Expand PET Exploration of Numerous Normal, Abnormal Brain Functions
Journal: JAMA (1986)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
ABSOLUTE ALCOHOL FOR SCIENTIFIC PURPOSES IS DUTY FREE.
Journal: JAMA (1893)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal
Error in Author Byline
Journal: JAMA Network Open (2020)

Rohan Khera, MD, MS; Ambarish Pandey, MD, MSCS; Colby R. Ayers, MS; Mercedes R. Carnethon, PhD; Philip Greenland, MD; Chiadi E Ndumele, MD, PhD; Vijay Nambi, MD, PhD; Stephen L. Seliger, MD, MS; Paulo H. M. Chaves, MD, PhD; Monika M. Safford, MD; Mary Cushman, MD, MSc; Vanessa Xanthakis, PhD; Ramachandran S. Vasan, MD; Robert J. Mentz, MD; Adolfo Correa, MD, MPH, PhD; Donald M. Lloyd-Jones, MD, ScM; Jarett D. Berry, MD, MS; James A. de Lemos, MD; Ian J. Neeland, MD
Yellow Fever.
Journal: JAMA (1884)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA HomeNew OnlineCurrent IssueFor Authors Podcasts Clinical Reviews Editors' Summary Medical News Author Interviews More Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA journal